Back to News
Market Impact: 0.3

Peek Under The Hood: USSG Has 11% Upside

USSGIFFRPRXTGTBRFHPMTDDINDAQ
Analyst EstimatesAnalyst InsightsCompany FundamentalsESG & Climate PolicyInvestor Sentiment & PositioningMarket Technicals & Flows
Peek Under The Hood: USSG Has 11% Upside

The Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) exhibits an implied analyst target price of $67.32, signaling a 10.93% upside from its recent $60.69 trading price, derived from the weighted average of its underlying holdings' 12-month forward targets. Notably, International Flavors & Fragrances (IFF), Royalty Pharma (RPRX), and Target Corp (TGT) are among the holdings with significant individual upside potential. The analysis, however, prompts investors to consider whether these analyst targets are justified or reflect potential over-optimism, necessitating further due diligence.

Analysis

Based on a weighted average of its underlying holdings' analyst targets, the Xtrackers MSCI USA ESG Leaders Equity ETF (USSG) shows an implied 10.93% upside, with a calculated target price of $67.32 versus a recent trading price of $60.69. This potential is significantly driven by a few key holdings with substantial upside to their respective consensus targets, namely International Flavors & Fragrances (IFF) at 33.22%, Royalty Pharma (RPRX) at 23.25%, and Target Corp (TGT) at 20.77%. While these figures suggest a bullish outlook from the analyst community, the analysis carries a cautionary tone, reflecting the provided 'uncertain' signal. It explicitly questions whether these high price targets are justified based on current fundamentals or are overly optimistic, potentially setting the stage for future downgrades if company or industry developments do not align with expectations.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo